Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Gallizzi

Orthopaedic Surgery of the Spine Lone Tree, CO Medical Doctor

NPI 1831327865 CMS profile 557650

10107 Ridgegate Pkwy Ste 370, Lone Tree, CO 80124

Open in the dashboard

General payments

$1,153,748

759 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Gallizzi of Lone Tree, CO is reported in the CMS Open Payments database as having received $1,153,748 across 759 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $398,685 183
2024 General $210,952 134
2023 General $170,403 122
2022 General $127,898 100
2021 General $99,908 74
2020 General $82,864 73
2019 General $63,037 73

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Gallizzi
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Michael Gallizzi were reported at $398,685. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Michael Gallizzi Orthopaedic Surgery of the Spine median Middle half National median
2019 $63,037 $2,106 $337–$18,608 $163
2020 $82,864 $1,213 $156–$15,082 $114
2021 $99,908 $1,834 $271–$15,617 $132
2022 $127,898 $2,015 $320–$17,036 $149
2023 $170,403 $1,925 $336–$14,599 $160
2024 $210,952 $2,110 $341–$12,483 $164
2025 $398,685 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $886,912 539 payments
  2. Globus Medical, Inc. $240,597 147 payments
  3. Cerapedics, Inc. $12,592 12 payments
  4. Medtronic, Inc. $8,303 11 payments
  5. Seaspine Orthopedics Corporation $1,833 12 payments
  6. Medtronic USA, Inc. $1,505 3 payments
  7. Integrity Implants Inc $552 6 payments
  8. Pylant Medical $212 6 payments
  9. Arteriocyte Medical Systems, Inc. $205 3 payments
  10. Ossur Americas., Inc $179 2 payments
  11. Other $859 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $578,242 76 payments
  2. Consulting Fee $431,872 108 payments
  3. Travel and Lodging $83,268 259 payments
  4. Royalty or License $44,086 14 payments
  5. Food and Beverage $16,280 302 payments
Products named General payments · program years 2019–2025
  1. Arthrex Biologics - Consumables - Autologous Cellular Products - Bone Marrow - Bone Marrow Concentrate $60,031 12 payments
  2. MARS 3VL $40,050 6 payments
  3. Arthrex Biologics - Consumables - Autologous Cellular Products - Bone Marrow - Bone Marrow Aspirate $40,020 8 payments
  4. Arthrex Biologics - Consumables - Autologous Cellular Products - Bone Marrow $23,577 8 payments
  5. Arthrex Biologics - Consumables - Autologous Cellular Products - Bone Marrow $23,577 8 payments
  6. EXCELSIUS GPS $20,506 8 payments
  7. Arthrex Biologics - Consumables - Autologous Cellular Products - Bone Marrow $15,913 4 payments
  8. Arthrex Biologics - Consumables - Autologous Cellular Products - Bone Marrow $15,913 4 payments
  9. Arthrex Biologics - Consumables - Autologous Cellular Products - Bone Marrow $15,913 4 payments
  10. MARS Anterior Retractor $15,300 3 payments
  11. Other $194,012 223 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$177,306

Medicare's payments for the services billed

Medicare patients

170

Average age 72

Services billed

701

84 women, 86 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 52%
Depression 19%
Ischemic heart disease 18%
Osteoporosis 18%
Cancer 11%
Diabetes 9%
Atrial fibrillation 8%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

759 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record